Inify reports sales of SEK 3.6 million in the quarter – up 62% compared to Q1. By the end of June, the laboratory had been open for over a year and had diagnosed more than 1,000 patients. More details about the laboratory operations and its success factors are discussed in a panel talk led by Ole Eikeland with Inify’s CEO Fredrik Palm and Laboratory Director Emelie Edvigsson. 

“The main difference for us since we started working with Inify is the time we save. Previously, we often had to call the pathology department to ask about missing test results and contact patients to reschedule due to delays. Now, we don’t have to deal with that at all.”